INTRODUCTION
Although focal nodular hyperplasia (FNH) is a benign disorder that frequently involves a problem of discrimination with regard to well-differentiated hepatocel{t § ~. ~ lular carcinoma, one exhibiting multiple lesions and an increasing tendency has been reported!). We report a case encountered recently in which the patient was diagnosed with FNH using tumor biopsy, performed twice. The number of nodules increased along with their size.
CASE REPORTS
A 14-year-old male was admitted to this department in May 2005 with the chief complaint of right hypochondrium pain.
This patient underwent bile-duct-to-jejunum anastomosis because of congenital biliary atresia at the age of 0 years and was diagnosed with cirrhosis using liver biopsy performed at that time. Endoscopic sclerotherapy was performed for gastric varices at the age of 5 years (1996) and 13 years (2004) .
In 2002, a 15-mm-diameter nodule that was identifiable by contrast imaging was pointed out for the first time in the SI region of the liver by abdominal CT examination. Although no change was found by CT performed the following year, similar multiple nodules were found by CT performed in July 2004 (Fig. 1) . Hepatocellular carcinoma also could not be ruled out. Findings obtained by percutaneous tumor biopsy suggested no histological malignancy and were supportive of FNH. The patient was clinically monitored.
According to examination obtained at the time of hospitalization, blood tests showed WBC 2,500/ ,uL, Hb 9.4 g/dL, and PLT 1.23 X 10 4 /,uL. Results of biochemical examination were AST 114 IU /L, AL T 75 IU /L, LDH 249 IU /L, ALP 1,508 IU / L, ALP 1,508 IU/L, yGTP 214 IU/L, and TB 1.9 mg/dL, indicating pancytopenia and hepatic function disorder. In addition, AFP 0.9 ng/mL, PIVKA-II 72 mAUl mL, CEA 1.0 ng/mL, CA 19-9<0.1 U/mL, and these tumor markers were at normal level, respectively. The CRP was 1.0 mg/dL, indicating a mild inflammatory reaction. Although the patient has a history of blood transfusion, hepatitis C and hepatitis B virus markers were both negative. The small bowel enema was performed to detect possible causes for abdominal pain revealed contracted or poorly dilated sites with afferent loop which were judged to be the causes of abdominal pain. Abdominal pain itself was relieved after fasting for several days; no symptoms recurred.
Many nodules of approximately 8-30 mm diameter that were densely stained from the early phase of contrast imaging CT were recognized. With some nodules, a slight contrast imaging effect was noticed at the central area, which was considered to reflect central scarring of FNH, although nodules without central scarring were visible. Compared with those obtained in 2004, the number of nodules had nearly doubled in 1 year from approximately 6 locations to approximately 12 locations, and their diameter had increased approximately 2-7 times as a result of lesions or nodules that were not recognized at all, which had subsequently emerged as new nodules (Figs. 1 and 2). Investigation by MRI revealed that F N I-I nodu les were depicted with high intensity under Tl WI after SPIO imaging a nd depicted with low intensity under T2WI. Of the FNI-I nod ul es, those having centra l scar were depicted vvith low intensity under Tl WI and were depicted with high intensity under T2WI (Fig . 3) .
By contrast imaging ultrasound examinati on by Levovist performed for S4 lesions, vascu lar fl ows were observed spread ing from the center to the periphery in a wheel pattern (Fig. 4) .
Compared with those obtained in 2004, the number of nodul es and their diameter were increased. Therefore, tumor biopsy was performed agai n (biopsy sites of 2004 and 2005 were different) . Pathologic findings revea led increased central scar and cholangiole-li ke structures; the obtained findings were not suggestive of any malignancy and a re consistent with those for FNI-I (Fig. 5) .
The patient is currentl y under observat ion through the outpatient department. c. Abno rm a l cholangiolar g rowth is ap parent within the centra l scar (I-IE sta ining, X 400 ) .
DISCUSSIO N 153
Proposed by Edmondson in 1958 , F N I-I is a non-neoplastic hyperplastic lesion. Although some reports show that it is freq uently found in sexuall y mature females 2 -,, ) , no difference is apparent in the rate of occurrence in males and fema les. Some reports indicate that cases among comparativel y younger subj ects, less than 15 years old, are as frequ ent as 33.3% 5).
Development of FNH and mecha nism of proliferation have not been clarified. Although cases attributable to invo lvement of oral contraceptives have been reported 6 -S ), some are unrelated, as typically represented by the current case 6 -S ).
Reportedl y, vascul a r abnormality is responsible for this disorder, whi ch has come to be vievved as the domin ant ca use.
Many cases are asymptomatic and the number of lesions reported is 1-2: Isa k et al. report that mul tiple cases with more than two nodules are as frequent as 32 .5% 3); Wan less el at. report 19%9); a nd Okudaira el al. report 4.5%'0) It has a lso been reported tha t the number of nodules is 2-5 at most and that FNH with more num erous nodules is rare1. 6) Because of remarkable developments made recently in im age diagnoses, the usefulness of CT, MRI, SPIO-MRI , scintigraphy, contr ast imagi ng ultrasound exam-ination and others have been reported ll ). In contrast-imaging CT, an asteroid-like low-absorption region that apparently reflects densely stained images from the early phase and central scar is shown as a typical example. Because SPIO-MRI is a useful examination that shows existence of Kupffer cells in the tumor 12 ), positive findings are obtained with FNH where Kupffer cells are equally present or more numerous than normal hepatic tissue at the periphery, which is used for discrimination from hepatocellular carcinoma yielding negative findingsll). In the meantime, in a typical example of contrast-imaging ultrasound examination, for FNH, arteries flowing into a tumor are recognized along with densely stained tumor images and a wheel-like angioarchitecture. It has been suggested that angiography will be unnecessary for future diagnosis of FNH13); this finding was confirmed in the current case in real time.
Although the current case is consistent with FNH from image and histological perspectives, compared with reports presented so far, the current case is very rare in that the number of tumors increased rapidly in a short period of time along with increased diameter. Kurachi et at. describe a case in which the 10 mm diameter tumor increases to 27 X 22 mm in 10 months and claim that this is comparable with the time for doubling hepatocellular carcinoma of less than 3 cm S ); in the current case, it is 2-7 times, which is considered to represent far faster growth than that of hepatocellular carcinoma.
In the current case, an examination performed in 1996 yielded no finding that was suggestive of FNH in the liver, but a rapid increase was recognized at recurrence of gastric varices. Therefore, association between manifestation of FNH and growth of FNH, and portal hypertension can not be ruled out. Chronological observation of lesions of Sl that existed from the early phase showed a difference of lesions' stainability, although the time phase of photography is slightly deviated. Apparently, the tumor diameter is somewhat reduced. Reports of lesions of FNH have not described changes other than unchanged or increased lesions. It is probable that, if FNH is attributable to increased hepatic perfusion, and if hemodynamics are changed because of progression of cirrhosis or treatment of varices, then the blood flow volume to the FNH is also changed, thereby engendering considerable changes in their imaging effects and size.
In the current case, FNH lesions continue to increase, even though the patient is asymptomatic. The possibility exists that if FNH progresses, but remains benign per se, progression of cirrhosis caused by original biliary atresia might be badly affected. It is therefore considered that presence of FNH might hasten the need for liver transplantation. Careful follow-up, including consideration of possible development of a malignant tumor, will be necessary.
